Nordic Nanovector ASA banner
N

Nordic Nanovector ASA
OSE:NANOV

Watchlist Manager
Nordic Nanovector ASA
OSE:NANOV
Watchlist
Price: 1.158 NOK -1.86% Market Closed
Market Cap: kr134.4m

Nordic Nanovector ASA
Investor Relations

Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The company is headquartered in Oslo, Oslo and currently employs 40 full-time employees. The company went IPO on 2014-07-07. The company is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product candidate is Betalutin, comprising a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide (Lutetium 177). The company is designed improve treatment of Non-Hodgkin Lymphoma (NHL) and advanced through clinical development. Additionally, the Company is engaged in the development of its Antibody-Radionuclide-Conjugate (ARC) portfolio to treat various selected cancer indications. The company has two subsidiaries, Nordic Nanovector GmbH and Nordic Nanovector Ltd.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2022
Call Date
Aug 31, 2022
Q2 2022 Earnings Call
No Analysis Available

This earnings call has not been analyzed yet.

If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.

Request Earnings Call Analysis
Other Earnings Calls

Management

Ms. Malene Brondberg
Interim CEO & CFO
No Bio Available
Dr. Jostein Dahle Ph.D.
Co-Founder & Chief Scientific Officer
No Bio Available
Dr. Lars Nieba Ph.D.
Chief Technology Officer
No Bio Available
Dr. Gabriele Elbl Ph.D.
VP Global Regulatory Affairs
No Bio Available
Mr. Fredrik Haavind
Head of Legal & Compliance
No Bio Available
Ms. Maureen Deehan
Head of Corp. Devel. & Strategy
No Bio Available
Dr. Reza Safaei
Head of Medical Affairs
No Bio Available
Dr. Mark Wright
Head of Manufacturing
No Bio Available

Contacts

Address
OSLO
Oslo
Kjelsasveien 168 B
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett